Stephan Kreher

Praxis für Hämatologie und Onkologie — Germany

Medicine · Health Sciences

19h-index1.5kcitations38works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(11), Immune Cell Function and Interaction(6), CNS Lymphoma Diagnosis and Treatment(5), Venous Thromboembolism Diagnosis and Management(4), Viral-associated cancers and disorders(4)

Publications38 total

Real-world treatment patterns and outcomes in and beyond first-line immune checkpoint inhibition in patients with HCC: Interim results from the prospective national intersectoral cohort study JADE
Zeitschrift für Gastroenterologie·2026
42P: First-line (1L) nivolumab (N) + ipilimumab (I) with 2 cycles of platinum-based chemotherapy (C) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC): Interim data from the German non-interventional study (NIS) FINN
Journal of Thoracic Oncology·2025Open Access
Table of Contents
2023Open Access
Diagnosis and treatment of MPN in real life: exploratory and retrospective chart review including 960 MPN patients diagnosed with ET or MF in Germany
Journal of Cancer Research and Clinical Oncology·2023· 5 citedOpen Access
Diagnosis and Treatment of MPN in Real Life - Interim-Analysis of an Exploratory Chart Review on 960 ET and MF Patients in Germany
Blood·2022
<scp>FOLFIRINOX</scp> or gemcitabine/nab‐paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision‐making in real‐world
International Journal of Cancer·2022· 10 citedOpen Access
Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL)
Cancers·2021· 6 citedOpen Access
Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism
Deutsches Ärzteblatt international·2019· 16 citedOpen Access
Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug–drug interactions
Critical Reviews in Oncology/Hematology·2018· 43 cited
Aktivierte Signalwege und Zytokinexpression in malignen Lymphomen
Refubium (Universitätsbibliothek der Freien Universität Berlin)·2018Open Access
Perioperative Medizin
2017· 4 cited
Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma
Leukemia·2016· 24 citedOpen Access
Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma
Journal of Neuro-Oncology·2016· 35 citedOpen Access
Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH)
Annals of Hematology·2016· 43 cited
CONKO-011: Evaluation der Patientenzufriedenheit bei der Behandlung akuter venöser Thromboembolien mit Rivaroxaban oder niedermolekularem Heparin bei Krebspatienten
DMW - Deutsche Medizinische Wochenschrift·2015· 8 cited
Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma
Neuro-Oncology·2015· 53 citedOpen Access
Cytokine and proinflammatory gene expression in classical Hodgkin lymphoma: Its more than NF-κB!
Cytokine·2015
Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.)
Annals of Hematology·2014· 68 cited
Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma
Proceedings of the National Academy of Sciences·2014· 55 citedOpen Access
Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trial
Annals of Hematology·2014· 27 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Stephan Mathas(11), Martin Janz(10), Björn Lamprecht(8), Korinna Jöhrens(8), Ioannis Anagnostopoulos(8), Bernd Dörken(8), Karl Köchert(7), Michael Hummel(6), Harald Stein(6), Hanno Riess(6), Hyun‐Dong Chang(4), Andreas Radbruch(4), Julia Richter(3), Kathrin D. Wurster(3), Maciej Giefing(3), Constanze Bonifer(3), Franziska Jundt(3), Uwe Niesner(3), Chalid Assaf(3), Wolfram Sterry(3)